Potent HIV fusion inhibitors against Enfuvirtide-resistant HIV-1 strains

T20 (generic name: Enfuvirtide, brand name: Fuzeon) is the only FDA-approved HIV fusion inhibitor that is being used for treatment of HIV/AIDS patients who have failed to respond to current antiretroviral drugs. However, it rapidly induces drug resistance in vitro and in vivo. On the basis of the st...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: He, Yuxian, Cheng, Jianwei, Lu, Hong, Li, Jingjing, Hu, Jie, Qi, Zhi, Liu, Zhonghua, Jiang, Shibo, Dai, Qiuyun
格式: Artigo
語言:Inglês
出版: National Academy of Sciences 2008
主題:
Biological Sciences
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2571013/
https://ncbi.nlm.nih.gov/pubmed/18852475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0807335105
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍